Mental Health
Mental Health
Mental Health
DEFINITION:
ACCORDING TO S.M. RAJU: IT IS MOST PROMINENT DEBILITATING AND EXPENSIVE ILLNESS IN ANY SCOIETY. ACCORDING TO L.P.SHAH & HEMA IT REFERS TO GROUP OF MENTAL ILLNESS CHARACTERISED BY SPECIFIC PSYCHOLOGICAL SYMPTOMS LEADING TO A DIS ORGANISATION OF THE PERSONALITY OF AN INDIVIDUAL.
INCIDENCE
IT ARISES FROM 25-30 YEARS OF AGE AND BOTH SEXES. 3-4 % IN 1000 POPULATION WERE AFFECTED IN COMMUNITY PER YEAR. ABOUT 1% ARE AT RISK ABOUT 15% OR NEW ADMISSION TO A MENTAL HOSPITAL FOR THIS CONDITION.
HIGHEST RISK IN LOW SOCIO ECONOMIC PEOPLE. 3.5 % IN 10-14 YEARS AND 24.3% 14-19 YEARS. MALE & FEMALE RATIO 3.5 : 1.5 A/C TO WORLD MENTAL HEALTH REPORT 2001: 24 MILLION PEOPLE ARE AFFECTED.
ETIOLOGY
BIOLOGICAL FACTORS:
VIRUS: VIRAL EXNCEPHALITIS. GENETIC FACTORS OR CHOROMOSMAL ABNORMALITIES. NEUROPATHOLOGY: DISREGULATION OF NEUROTRANSMITTER, HEAD INJURY, CVA, BIRTH TRAUMA.
BIOCHEMICAL FACTORS:
INDOLAMINE HYPOTHESIS.
PSYCHOLOGICAL FACTORS:
PERSONS WHO ARE WITHDRAWN AND HAVE VERY FEW SOCIAL CONTACT ARE MORE PRONE TO DEVELOP SCHIZOPHERNIC ILLNESS.
SOCIAL OR CULTURAL :
DIVORCE FAMILIES. CULTURAL BELIEFS. INDUSTRALISATION. POVERTY. INADEQUATE NUTRITION. FEELING OF HOPELESSNESS. HOME ENVIRONMENT.
CLASSIFICATION
TYPICAL ATYPICAL ICD 10. COURSE OF ILLNESS.
CLASSIFICATION:
TYPICAL TYPE: - CATOTONIC SCHIZOPHERNIA. - PARNOID SCHIZOPHERNIA. - HEBEPHERNIC SCHIZOPHERNIA. - SIMPLE SCHIZOPHERNIA. - UNDIFFERENTIAL OR MIXED SCHIZOPHERNIA.
ATYPICAL TYPE: - CHILDHOOD & JUVENILE - LATE SCHIZOPHERNIA : 40 YEARS - SCHIZO AFFECTIVE (MANIA) - PSEUDONEUROTIC SCHIZOPHERNIA. - RESIDUAL AND LATENT SCHIZOPHERNIA
A/C TO ICD-10:
POST-SCHIZOPHERNIA DEPRESSION.(12 MONTHS) PSEUDONEUROTIC SCHIZOPHERNIA (1 YEAR) SCHIZOPHERIFORM (<6 MONTHS) ONEIROID: PERCETION DISTURBANCE VONGOGH SYNDROME (MUTILATION) LATE PARAPHERNIA (WOMEN) NEGATIVE SCHIZOPHERNIA PTROPF SCHIZOPHERNIA (MR).
SUB CHRONIC: LESS THAN 2YEARS 6 MONTHS. CHRONIC : MORE THAN 2 YEARS. COURSE SCHIZOPHERNIA: EXACERBATION AND RELATIVE REMISSION.
CLINICAL MANIFESTATION:
POSITIVE SYMPTOMS: - HALLUCINATIONS - DELUSIONS - TALKING NONSENSE - PRE-OCCUPATION - VIOLENT OR AGGRESSIVE BEHAVIOUR - PERSERVATION - FLIGHT OF IDEAS.
NEGATIVE SYMPTOMS: - FLATTENED AFFECT - SOCIAL WITHDRAWL - SUICIDAL THOUGHT - LACK OF MOTIVATION - AMBIVALENCE - THOUGHT DISTURBANCE - AUTISM - EMOTIONAL DISTURBANCE
DIAGNOSTIC ASSESMENT:
HISTORY COLLECTION. PHYSICAL EXAMINATION. SKULL X-RAY STUDIES. CT SCAN AND MRI SCAN. POSITRON EMISSION TOMOGRAPHY. EEG. EVOKED POTENTIAL STUDIES INVASIVE PROCEDURES.
MANAGEMENT
MEDICAL MANAGEMENT. ELECTRO-CONVULSIVE THERAPY. PSYCHO THERAPY. BEHAVIOUR MODIFICATION THERAPY. SOCIAL THERAPY. MILIEU THERAPY. FAMILY THERAPY. GROUP THERAPY. INDIVIDUAL THERAPY.
DRUG THERAPY:
CLOZAPINE IT BINDS DOPAMINE RECEPTORS. THIORIDAZINE EXERT THE POST SYNPATIC BLOCKAGE. PROCHLOROPEAZINE INHIBIT THE BLOCKAGE OF RECEPTORS. HALOPERIDOL EXERT OF ANTIPSYCHOTIC EFFECTS.
DIET THERAPY
VEG
NURSING MANAGEMENT:
ALTERED THOUGHT PROCESS EVIDENCED BY DELUSION R/T INABILITY TO PROCESS AND SYNTHESIZE INFORMATION. SOCIAL ISOLATION EVIDENCED BY WITHDRAWL. ALTERED CO-OPERATION R/T MENTAL ILLNESS.
ALTERED THOUGHT PROCESS EVIDENCED BY HALLUCINATION, DELUSIONS EXAGGREGATED RESPONSES R/T INABILITY TO EVALUATE REALITY. IMPARIED VERBAL COMMUNICATION EVIDENCED BY FLIGHT OF IDEAS. DISTURBED SELFESTEM R/T REPEATED FAILURE BY WORTHLESSNESS HOPELESSNESS.
THANK Q